Potentially Inappropriate Prescribing to Older Patients: Criteria, Prevalence and an Intervention to Reduce It: The Prescription Peer Academic Detailing (Rx-PAD) Study - A Cluster-Randomized, Educational Intervention in Norwegian General Practice

Basic & Clinical Pharmacology & Toxicology
Sture RognstadArne Fetveit

Abstract

Potentially inappropriate prescriptions (PIP) is drug treatment, which in general, at the group level for a median/mean patient, can be considered unfavourable meaning that the risks commonly may outweigh the benefits. This MiniReview reports and discusses the main findings in a large cluster-randomized educational intervention in Norwegian general practice, aimed at reducing the prevalence of PIPs to patients ≥70 years (The Rx-PAD study). Targets for the intervention were general practitioners (GPs) in continuing medical education (CME) groups receiving educational outreach visits (i.e. peer academic detailing). A Delphi consensus process, with a panel of medical experts, was undertaken to elaborate a list of explicit criteria defining PIPs for patients ≥70 years in general practice. Agreement was achieved for 36 explicit PIP criteria, the so-called Norwegian General Practice (NorGeP) criteria. Using a selection (n = 24) of these criteria during a 1-year baseline period on the prescribing practice of 454 GPs (i.e. those enrolled to participate in the intervention trial), we found a prevalence rate of 24.7 PIPs per 100 patients ≥70 years per year. In the Rx-PAD study, 449 GPs completed an educational intervention (96.6% of the ...Continue Reading

References

Apr 29, 1998·JAMA : the Journal of the American Medical Association·J LazarouP N Corey
Oct 27, 1999·JAMA : the Journal of the American Medical Association·M D CabanaH R Rubin
Jun 10, 2000·Quality in Health Care : QHC·P van den HomberghW J van den Bosch
Nov 10, 2000·Lancet·I R Edwards, J K Aronson
Apr 5, 2001·Journal of Clinical Pharmacy and Therapeutics·S M Campbell, J A Cantrill
Jul 31, 2001·Family Practice·M CranneyT Walley
Sep 29, 2001·Journal of Internal Medicine·I BuajordetT Hilberg
Aug 15, 2002·Journal of Epidemiology and Community Health·E Bernal-DelgadoS Peiró-Moreno
Jun 24, 2004·Annals of Family Medicine·Shersten KillipKevin Pearce
Oct 19, 2004·BMC Geriatrics·Carol RancourtJean-Pierre Grégoire
Feb 3, 2007·Postgraduate Medical Journal·Bisanth Thushila BatuwitageRuth Louise Bartlett
Apr 27, 2007·The New England Journal of Medicine·Eric G CampbellDavid Blumenthal
Jul 5, 2007·BMC Medical Research Methodology·Rob McCarneyPeter Fisher
Dec 12, 2007·British Journal of Clinical Pharmacology·Karin WesterStaffan Hägg
Jan 26, 2008·International Journal of Clinical Pharmacology and Therapeutics·P GallagherD O'Mahony
Apr 9, 2008·The American Journal of Geriatric Pharmacotherapy·Andrea M WessellSteven M Ornstein
Sep 16, 2008·BMC Medical Informatics and Decision Making·Anneke L FranckePatriek Mistiaen
Feb 22, 2012·European Journal of Clinical Pharmacology·Gunhild NyborgMette Brekke
May 31, 2012·Drugs & Aging·Marie N O'ConnorDenis O'Mahony
Aug 27, 2013·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Sture RognstadJørund Straand
Sep 11, 2013·European Journal of Clinical Pharmacology·Carole P KaufmannMarkus L Lampert
May 8, 2014·European Journal of Clinical Pharmacology·Björn BelfrageSusanna M Wallerstedt
May 15, 2015·European Journal of Clinical Pharmacology·Anna Renom-GuiterasPetra A Thürmann
Jul 7, 2015·Pharmacoepidemiology and Drug Safety·Susanna M WallerstedtJohan Fastbom
Mar 3, 2017·European Journal of Clinical Pharmacology·T J OscanoaAlfonso Carvajal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.